Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study
MTC Poon, S Keni, V Vimalan, C Ip… - Neuro-Oncology …, 2021 - academic.oup.com
Background MGMT methylation in glioblastoma predicts response to temozolomide but
dichotomizing methylation status may mask the true prognostic value of quantitative MGMT …
dichotomizing methylation status may mask the true prognostic value of quantitative MGMT …
Extent of MGMT Promoter Methylation Modifies the Effect of Temozolomide on Overall Survival in Patients with Glioblastoma: A Regional Cohort Study
MTC Poon, S Keni, V Vimalan, C Ip, C Smith… - Neuro …, 2022 - ncbi.nlm.nih.gov
AIMS MGMT methylation in glioblastoma predicts response to temozolomide but dichotomizing
methylation status may mask the true prognostic value of quantitative MGMT methylation. …
methylation status may mask the true prognostic value of quantitative MGMT methylation. …
CORE-IBD: a multidisciplinary international consensus initiative to develop a core outcome set for randomized controlled trials in inflammatory bowel disease
Background & Aims End points to determine the efficacy and safety of medical therapies for
Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in …
Crohn’s disease (CD) and ulcerative colitis (UC) are evolving. Given the heterogeneity in …
[BOOK][B] Complexity theory and planning: Methodological insights
AC Rajan - 2005 - search.proquest.com
… My two children Vinay and Vineeth have in many ways that they perhaps do not realise … and
the silent patience of my husband Vimalan in putting up with my absence for this long period. …
the silent patience of my husband Vimalan in putting up with my absence for this long period. …
Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries
TASMAN Collaborative, C Varghese - medRxiv, 2023 - medrxiv.org
Background Excessive post-surgical opioid prescribing is contributing to the growing opioid
crisis. Prescribing practices are modifiable, yet data to guide appropriate prescription of …
crisis. Prescribing practices are modifiable, yet data to guide appropriate prescription of …
Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of …
L Guillo, M Abreu, R Panaccione… - The Lancet …, 2022 - thelancet.com
Extraintestinal manifestations occur frequently in patients with inflammatory bowel disease (IBD)
and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for …
and remain a diagnostic and therapeutic challenge. The aim of the Endpoints for …
Comparative studies on formation and material characterization of L-histidine derivatives for nonlinear optical device applications
HM Albert, CA Gonsago - Journal of Materials Science: Materials in …, 2022 - Springer
In this study, nonlinear optical crystalline materials L-histidinium hydrochloride monohydrate
(LHHCL) and L-histidinium methyl ester dihydrochloride (LHMDHCL) were successfully …
(LHHCL) and L-histidinium methyl ester dihydrochloride (LHMDHCL) were successfully …
IOIBD recommendations for clinical trials in ulcerative proctitis: the PROCTRIAL consensus
B Caron, MT Abreu, CA Siegel, R Panaccione… - Clinical …, 2022 - Elsevier
Background & Aims Clinical trials evaluating biologics and small molecules in patients with
ulcerative colitis are predominantly excluding ulcerative proctitis. The objective of the …
ulcerative colitis are predominantly excluding ulcerative proctitis. The objective of the …
[PDF][PDF] Patterns of opioid use after surgical discharge: a multicentre, prospective cohort study in 25 countries
T Collaborative - academia.edu
Methods We performed an international, prospective, multicentre, cohort study between 4
April 2022 and 4 September 2022 among adult patients undergoing common general, …
April 2022 and 4 September 2022 among adult patients undergoing common general, …
[CITATION][C] Neuro-Oncology Advances
MTC Poon, S Keni, V Vimalan, C Ip, C Smith, S Erridge… - 2021